Susquehanna International Group’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-238,307
| Closed | -$8.21M | – | 5575 |
|
2020
Q3 | $8.21M | Buy |
238,307
+12,477
| +6% | +$430K | ﹤0.01% | 621 |
|
2020
Q2 | $3.77M | Buy |
225,830
+17,658
| +8% | +$295K | ﹤0.01% | 983 |
|
2020
Q1 | $3M | Sell |
208,172
-17,680
| -8% | -$255K | ﹤0.01% | 994 |
|
2019
Q4 | $7.56M | Buy |
225,852
+40,863
| +22% | +$1.37M | ﹤0.01% | 652 |
|
2019
Q3 | $3.87M | Buy |
184,989
+92,336
| +100% | +$1.93M | ﹤0.01% | 778 |
|
2019
Q2 | $1.93M | Buy |
92,653
+24,119
| +35% | +$502K | ﹤0.01% | 1302 |
|
2019
Q1 | $1.53M | Sell |
68,534
-39,161
| -36% | -$875K | ﹤0.01% | 988 |
|
2018
Q4 | $2.58M | Buy |
+107,695
| New | +$2.58M | ﹤0.01% | 800 |
|
2018
Q3 | – | Sell |
-11,470
| Closed | -$308K | – | 5189 |
|
2018
Q2 | $308K | Sell |
11,470
-124,801
| -92% | -$3.35M | ﹤0.01% | 2679 |
|
2018
Q1 | $4.34M | Buy |
136,271
+120,960
| +790% | +$3.85M | ﹤0.01% | 564 |
|
2017
Q4 | $579K | Sell |
15,311
-37,953
| -71% | -$1.44M | ﹤0.01% | 2282 |
|
2017
Q3 | $1.32M | Buy |
+53,264
| New | +$1.32M | ﹤0.01% | 1434 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 4716 |
|
2017
Q1 | – | Sell |
-45,094
| Closed | -$922K | – | 4811 |
|
2016
Q4 | $922K | Buy |
+45,094
| New | +$922K | ﹤0.01% | 2338 |
|
2016
Q3 | – | Sell |
-19,164
| Closed | -$207K | – | 4308 |
|
2016
Q2 | $207K | Buy |
+19,164
| New | +$207K | ﹤0.01% | 2731 |
|
2015
Q4 | – | Sell |
-38,373
| Closed | -$972K | – | 4772 |
|
2015
Q3 | $972K | Buy |
+38,373
| New | +$972K | ﹤0.01% | 2463 |
|